Vycor Medical (VYCO) Net Cash Flow Growth (1y) (2011 - 2026)
Vycor Medical (VYCO) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 76.43% |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 294.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 294.29% |
| Dec 31, 2025 | 143.77% |
| Sep 30, 2025 | -192.52% |
| Jun 30, 2025 | -45.08% |
| Mar 31, 2025 | -231.99% |
| Dec 31, 2024 | -341.94% |
| Sep 30, 2024 | 144.98% |
| Jun 30, 2024 | 1,247.37% |
| Mar 31, 2024 | -224.74% |
| Dec 31, 2023 | -363.45% |
| Sep 30, 2023 | 241.62% |
| Jun 30, 2023 | 116.59% |
| Mar 31, 2023 | 203.85% |
| Dec 31, 2022 | -63.91% |
| Sep 30, 2022 | 63.31% |
| Jun 30, 2022 | -148.46% |
| Mar 31, 2022 | -48.90% |
| Dec 31, 2021 | 142.77% |
| Sep 30, 2021 | -864.75% |
| Jun 30, 2021 | 490.18% |